Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma

被引:1
作者
DengFu Yao XinHua Wu Yong Zhu GongSheng Shi ZhiZhen Dong DengBing Yao Wei Wu LiWei Qiu and XianYong Meng Nantong China Research Center of Clinical Molecular Biology Department of Pathology and Department of Gastroenterology Affiliated Hos pital of Nantong University
Department of Diagnostics and Institute of Neurosciences Nantong University
Nantong China [226001 ]
机构
关键词
vascular endothelial growth factor; hepatocellular carcinoma; ELISA; microvascular density; immunohistochemistry;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND: Angiogenesis is known to be essential to the survival, growth, invasion, and metastasis of tumor cells. Vascular endothelial growth factor (VEGF) are an important angiogenic factor regulating tumor angiogenesis, but its significance and tumor pathologic features are un- clear in hepatocellular carcinoma (HCC). In the present study, we analyzed expression of tissue VEGF, alteration of microvascular density (MVD) in microvessel angiogenesis, development and metastasis of HCC, and level of serum VEGF in differential diagnosis of benign and malignant liv- er diseases. METHODS: Tumor specimens were prospectively collected from HCC patients undergoing resection. Total RNAs were extracted and the expression levels were detected from different parts of HCC tissues. The cellular distributions of VEGF and MVD of liver tumors and their paracancerous and distal cancerous tissues were investigated by streptavi- din peroxidase (S-P) immunohistochemistry, respectively. The VEGF levels of circulating blood and hepatoma tissues were measured by enzyme-linked immunosorbent assay. RESULTS: The incidence of VEGF expression was 63.9% in HCCs (23/36 cases), 78.3% in non-encapsulated HCCs (18/23), and 90.9% in HCCs with extrahepatic metastasis (10/11), respectively. The VEGF expression was tightly correlated with MVD (P <0.01). The MVD in HCC with metastasis, low differentiation or non-encapsulation was significantly higher than that in HCC with intact capsule, high differentiation, or no metastasis. No significant diffe- rence was found between VEGF, MVD, tumor size, and hepatitis virus infection. The level of total RNA in HCC tis- sues was significantly lower but the VEGF level significantly higher than those in paracancerous or distal cancerous ones (P<0.01). The abnormal expression levels of VEGF in sera of HCC patients were directly correlated with the me- tastasis and recurrence of tumors. CONCLUSION: The high expression of VEGF and abnor- mality of tissue MVD are useful predictors for vascular inva- sion and metastasis of liver tumors.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 16 条
[1]   Risk factors for hepatocellular carcinoma in patients with cirrhosis [J].
Sarbah, SA ;
Gramlich, T ;
Younoszai, A ;
Osmack, P ;
Goormastic, M ;
Grosso, L ;
Cooper, JN ;
Di Bisceglie, A ;
Seneca, R ;
Younossi, ZM .
DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (05) :850-853
[2]  
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature[J] . Lun-Xiu Qin,Zhao-You Tang.Journal of Cancer Research and Clinical Oncology . 2004 (9)
[3]   Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma [J].
Cheng, ASL ;
Chan, HLY ;
To, KAF ;
Leung, WK ;
Chan, KK ;
Liew, CT ;
Sung, JJY .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (04) :853-860
[4]   Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis [J].
Ng, IOL ;
Guan, XY ;
Poon, RTP ;
Fan, ST ;
Lee, JMF .
JOURNAL OF PATHOLOGY, 2003, 199 (03) :345-353
[5]  
Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery[J] . Yee Chao,Chung-Ping Li,Gar-Yang Chau,Chih-Ping Chen,Kuang-Liang King,Wing-Yiu Lui,Sang-Hue Yen,Full-Young Chang,Wing-Kai Chan,Shou-Dong Lee.Annals of Surgical Oncology . 2003 (4)
[6]  
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications[J] . Masakazu Toi,Tomoe Matsumoto,Hiroko Bando.Lancet Oncology . 2001 (11)
[7]   Kinetics of tumorigenic vascular endothelial growth factor signalling and its significance in human hepatocellular carcinoma cells [J].
Fang, Y ;
Hu, M ;
Liu, K .
BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (02) :102-110
[8]   Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues [J].
Yamaguchi, R ;
Yano, H ;
Nakashima, Y ;
Ogasawara, S ;
Higaki, K ;
Akiba, J ;
Hicklin, DJ ;
Kojiro, M .
ONCOLOGY REPORTS, 2000, 7 (04) :725-729
[9]   Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma [J].
An, FQ ;
Matsuda, M ;
Fujii, H ;
Matsumoto, Y .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (03) :153-160
[10]  
[J] . Napoleone Ferrara.Journal of Molecular Medicine . 1999 (7)